TickerFacts.

Zhengye Biotechnology Holding Ltd (ZYBT): Net Income

Annual figures by period end, from SEC filings.

-69.78M CNY
Year ended 2025-12-31
46.73M CNY2022-12-31: 46.73M CNY2023-12-31: 31.46M CNY2024-12-31: 11.31M CNY2025-12-31: -69.78M CNY-69.78M CNY
2022-12-31 Net Income (CNY) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-69.78M CNYn/m2026-04-28, From 2025-01-01
2024-12-3111.31M CNY-64.0%2026-04-28, From 2024-01-01
2023-12-3131.46M CNY-32.7%2026-04-28, From 2023-01-01
2022-12-3146.73M CNYn/a2025-07-03, From 2022-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-31-69.78M CNYn/m
Yatsen Holding Ltd (YSG)2025-12-31-80.87M CNYn/m

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗